MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/13872877251333802

Медицинская библиотека · Journal of Alzheimer's disease : JAD · 2025

Alpha-1-acid glycoprotein as a potential serum biomarker for cerebral amyloid angiopathy.

Nishigaki Akisato, Ishikawa Hidehiro, Nishiguchi Yamato, Tachibana Kei, Kato Natsuko, Matsuda Kana, Mori Yurie, Matsuyama Hirofumi, Matsuura Keita, Ii Yuichiro, Wakita Hideaki, Oikawa Shinji, Tomimoto Hidekazu, Shindo Akihiro

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BackgroundCerebral amyloid angiopathy (CAA) is a form of cerebral small vessel disease (SVD) associated with Alzheimer's disease, intracerebral hemorrhage, and cognitive decline. Despite its clinical significance, no reliable serum biomarker exists for early diagnosis or monitoring of disease progression.ObjectiveThis study hypothesizes that α1-acid glycoprotein (α1-AGP) and other serum biomarkers can aid CAA diagnosis and assessment using gel-based mass spectrometry. A comparative analysis was performed to investigate associations between serum biomarkers and radiological scores.MethodsSerum proteins from individuals with probable or possible CAA (n = 10), classified using the modified Boston criteria, and age-matched controls (n = 10) were analyzed via two-dimensional differential gel electrophoresis (2D-DIGE) and matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry (MALDI-TOF/TOF-MS). Candidate proteins were validated using enzyme-linked immunosorbent assay (ELISA). Outcome measures included biomarker diagnostic accuracy, assessed by receiver operating characteristic (ROC) curve analysis, and correlations between α1-AGP levels and CAA-SVD scores.ResultsFour proteins-hemopexin, complement C3, complement C9, and α1-AGP-were significantly elevated, while apolipoprotein A-1 was reduced in the CAA group. ELISA confirmed higher α1-AGP levels in individuals with CAA (p < 0.0001). ROC analysis demonstrated that α1-AGP could indicate the presence of CAA with a sensitivity and specificity of 1.00 (95%CI: 1.000, 1.000). Additionally, α1-AGP levels correlated with the CAA-SVD score (R² = 0.783).Conclusionsα1-AGP may serve as a novel serum biomarker for CAA. Larger cohorts and external validation are required to substantiate these findings and determine their clinical relevance.

Для цитирования: Nishigaki Akisato, Ishikawa Hidehiro, Nishiguchi Yamato, Tachibana Kei, Kato Natsuko, Matsuda Kana, Mori Yurie, Matsuyama Hirofumi, Matsuura Keita, Ii Yuichiro, Wakita Hideaki, Oikawa Shinji, Tomimoto Hidekazu, Shindo Akihiro. Alpha-1-acid glycoprotein as a potential serum biomarker for cerebral amyloid angiopathy.. Journal of Alzheimer's disease : JAD. 2025. DOI: 10.1177/13872877251333802.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.